1. Home
  2. LGND vs BBUC Comparison

LGND vs BBUC Comparison

Compare LGND & BBUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • BBUC
  • Stock Information
  • Founded
  • LGND 1987
  • BBUC 2022
  • Country
  • LGND United States
  • BBUC United States
  • Employees
  • LGND N/A
  • BBUC N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • BBUC
  • Sector
  • LGND Health Care
  • BBUC
  • Exchange
  • LGND Nasdaq
  • BBUC Nasdaq
  • Market Cap
  • LGND 2.0B
  • BBUC 1.7B
  • IPO Year
  • LGND 1992
  • BBUC N/A
  • Fundamental
  • Price
  • LGND $102.19
  • BBUC $28.53
  • Analyst Decision
  • LGND Strong Buy
  • BBUC
  • Analyst Count
  • LGND 8
  • BBUC 0
  • Target Price
  • LGND $144.71
  • BBUC N/A
  • AVG Volume (30 Days)
  • LGND 118.3K
  • BBUC 80.9K
  • Earning Date
  • LGND 05-08-2025
  • BBUC 01-01-0001
  • Dividend Yield
  • LGND N/A
  • BBUC 0.88%
  • EPS Growth
  • LGND N/A
  • BBUC N/A
  • EPS
  • LGND N/A
  • BBUC N/A
  • Revenue
  • LGND $181,488,000.00
  • BBUC $8,309,000,000.00
  • Revenue This Year
  • LGND $17.68
  • BBUC N/A
  • Revenue Next Year
  • LGND $18.69
  • BBUC N/A
  • P/E Ratio
  • LGND N/A
  • BBUC N/A
  • Revenue Growth
  • LGND 53.40
  • BBUC 8.15
  • 52 Week Low
  • LGND $77.43
  • BBUC $18.21
  • 52 Week High
  • LGND $129.90
  • BBUC $30.00
  • Technical
  • Relative Strength Index (RSI)
  • LGND 44.63
  • BBUC 57.22
  • Support Level
  • LGND $98.90
  • BBUC $27.64
  • Resistance Level
  • LGND $103.17
  • BBUC $28.83
  • Average True Range (ATR)
  • LGND 3.05
  • BBUC 0.76
  • MACD
  • LGND -0.27
  • BBUC -0.13
  • Stochastic Oscillator
  • LGND 31.94
  • BBUC 37.71

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares

Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a world-wide basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.

Share on Social Networks: